Objective To understand the strains type,clinical typing,severity rate and hospitalization costs of COVID-19 cases,and provide reference basis for the prevention and treatment. Methods Relevant information to COVID-19 cases admitted to the First Affiliated Hospital of the University of Science and Technology of China,Infectious Disease Hospital Area (Hefei Infectious Disease Hospital) from November 2022 to January 2023 was collected,the proportion of strains,clinical subtypes,severity rate,treatment costs,and other related indicators were calculated.Perform statistical analysis using SPSS 26.0. Results A total of 90 COVID-19 cases were investigated,including 63 males and 27 females,aged from 27 to 96 years old.32 cases were mild from clinical classification (35.56%),47 cases were common (52.22%),and 11 cases were severe (12.22%).The distribution of strains were as follows: 57 cases (63.33%) were infected with BA.5.2.48,25 cases (27.78%) were infected with BF.7.14,and 8 cases (8.89%) were infected with other subtypes.There were 50 cases (55.56%) with underlying diseases and 40 cases (44.44%) without underlying diseases.The hospitalization cost of severe cases was higher than that of ordinary cases and mild cases (H=32.658,P<0.001),and the hospitalization cost of cases with underlying diseases was higher than those without underlying diseases (Z =5.903,P<0.001).The severity rate of patients with underlying diseases (20.00%) was higher than that of those without underlying diseases (2.50%) (PFisher=0.019). Conclusion COVID-19 cases are mainly common and mild,with the main strains of BA.5.2.48 and BF.7.14.The treatment costs for severe cases and cases with underlying diseases are relatively high.
Key words
COVID-19 /
SARS-CoV-2 /
Clinical features /
Hospitalization expenses
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 赵青,纪瀚然,武洁雯,等.2022年11月全球新型冠状病毒肺炎疫情风险评估[J].疾病监测,2022,37(12):1515-1519.
[2] Dong GY,Jin FF,Huang Q,et al.Exploratory COVID-19 death risk score based on basic laboratory tests and physiological clinical measurements[J].World J Emerg Med,2022,13(6):453-458.
[3] 顾微,彭平,陈沐,等.新型冠状病毒变异毒株感染的临床特征与预警因素分析[J].中国热带医学,2023,23(2):162-166.
[4] 张明丽,向保云,邵玉芬,等.河南省某定点医院356例14岁以上新型冠状病毒奥密克戎变异株感染者临床特征[J].河南预防医学杂志,2023,34(2):153-155.
[5] 聂爽,陈秀芝,宋丹丹,等.新型冠状病毒感染长期症状研究进展[J].安徽预防医学杂志,2024,30(2):117-119+146.
[6] 王海,王卓莉,裴红红,等.西安市2021—2022年跨年期间新型冠状病毒感染重症病例的危险因素分析及预测指标研究[J].中国全科医学,2023,26(17):2132-2137.
[7] 吴雪华,钱峰,许炜璐,等.苏州地区142例新型冠状病毒奥密克戎变异株感染者的临床特征分析[J].抗感染药学,2022,19(12):1707-1711+1730.
[8] 高伟林,伊发英,叶和义,等.安庆市2020年新冠肺炎疫情流行病学分析[J].安徽预防医学杂志,2021,27(3):196-198+211.
[9] 庞裕,齐玉晶,何志义,等.广西144例家族聚集性新型冠状病毒奥密克戎变异株感染者的临床特征分析[J].解放军医学院学报,2022,43(12):1242-1247.
[10] 于乐成,宋勇.新型冠状病毒奥密克戎变异株的病原学、临床特点、感染控制及治疗[J].解放军医学杂志,2022,47(11):1063-1072.
[11] 何军,罗婉蓉,夏艺丹,等.新型冠状病毒变异株的演化与研究进展[J].安徽预防医学杂志,2023,29(4):317-323+331.
[12] 毕念念,龚磊,肖永康,等.新型冠状病毒Omicron变异株感染者临床特征分析[J].安徽预防医学杂志,2024,30(2):97-102.
[13] 王海峰,李亚飞,潘静静,等.≥60岁老年人群感染不同新冠病毒变异株临床症状及严重程度分析[J].中国公共卫生,2022,38(8):968-974.
[14] 王军,原跃礼,张艳,等.河南省焦作市60岁及以上老年人新型冠状病毒疫苗未接种影响因素及原因分析[J].现代疾病预防控制,2023,34(5):331-337.
[15] 陈丽丽,尤恩情,刘旭祥,等.合肥市新型冠状病毒肺炎病例的“早发现” 分析[J].安徽预防医学杂志,2021,27(1):10-15.